15.000
+0,00%
2026-10-19
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -44.0% | -9.5% | 1 / 3 | -56.5% | +34.51 pp | +3.49 pp | +31.8% | 0.06 | 2.35 | 29,9 | −56,5% | 2,1 | −13,3% | 2.35 | 24.39 | −90,4% |
| Pts | 0 | 0 | 4 | 0 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 15.000 (close price on 2026-10-19)EPS (TTM): 6.374
Financial charts
1.Revenue & growth
VND bn29,8Q2/26
1.Revenue & growth
VND bn29,8Q2/26
2.Profit & growth
VND bn1,43Q2/26
3.Profit mix (Penman)
VND bn21,5Q2/26
4.Margins & cost structure
%75.5%Q2/26
5.Returns & cash cycle
% · days39.5%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn73,3Q2/26
8.Funding & debt health
VND bn · times73,3Q2/26
9.Revenue backlog
VND bn0,07Q2/26
10.Valuation
times · %4,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %461Q2/26
Adjusted EPS growth, latest quarter
-40.9%
Average adjusted EPS growth, 3 quarters
31.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26